EUVIMEDEUVIMED entdecken
Übersichtsarbeit

P2X2/3 receptors as a potential target for cancer pain treatment

Ying-Lei Yu, Wei Xu, Si-Hui Xie, Ri-Xin Chen, Tao Yang

Behavioural Brain Research · 2026-05 · 506 · 116149

DOI: 10.1016/j.bbr.2026.116149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Behavioural Brain Research, 2026-05. Verfasst von Ying-Lei Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X3, Cancer Pain, Receptors, Purinergic P2X2, Purinergic P2X Receptor Antagonists. Die Arbeit nennt 179 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the process of tumor growth and metastasis, which can invade nerve tissue, sensitize peripheral receptors, enhance sensory information transmission and induce pain. Bone cancer pain is the most common type of cancer pain, caused by primary bone tumors or other types of cancer metastasis, destruction and dissolution of bone tissue, leading to pain generation. The pathological mechanism of cancer pain is complex and its treatment is a thorny problem at present. P2X2/3 receptors are mainly expressed in nociceptive sensory neurons. ATP released by cells is involved in nociceptive and pain signal transduction by activating or sensitizing P2X2/3 receptors. ATP-activated P2X2/3 receptors can produce rapid or continuous desensitized transient current, resulting in abnormal activity of sensory neurons and enhanced synaptic plasticity, sensitizing the central nervous system and leading to pain. A few studies have shown that P2X2/3 receptors may play a regulatory role in tumor progression, which also strengthens the functional role of P2X2/3 receptors in cancer pain. However, the use of P2X2/3 receptors antagonists (such as A31749 and AF-353) can antagonize the activation of P2X2/3 receptors and have pharmacological effects on pain relief. Therefore, in this article, we discuss the potential relationship between P2X2/3 receptors and cancer pain and its potential pharmacological target for the treatment of cancer pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Purinergic P2X3Cancer PainReceptors, Purinergic P2X2Purinergic P2X Receptor AntagonistsHumansAnimals

Stichwörter der Autor:innen

AntagonistsCancer painP2X2/3 receptorsTreatmentTumors

Substanzen

Receptors, Purinergic P2X3Receptors, Purinergic P2X2Purinergic P2X Receptor Antagonists

Autor:innen und Institutionen

  • The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.
  • Department of Rehabilitation Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.
  • School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang City, China.
  • Emergency department, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China. Electronic address: xm1991j@163.com.

Zitieren

APA

Yu, Y. L., Xu, W., Xie, S. H., Chen, R. X., & Yang, T. (2026). P2X2/3 receptors as a potential target for cancer pain treatment. Behavioural Brain Research, 506, 116149. https://doi.org/10.1016/j.bbr.2026.116149

Vancouver

Yu YL, Xu W, Xie SH, Chen RX, Yang T. P2X2/3 receptors as a potential target for cancer pain treatment. Behavioural Brain Research. 2026;506:116149. doi:10.1016/j.bbr.2026.116149

BibTeX
@article{Yu2026,
  author = {Yu, Ying-Lei and Xu, Wei and Xie, Si-Hui and Chen, Ri-Xin and Yang, Tao},
  title = {P2X2/3 receptors as a potential target for cancer pain treatment},
  journal = {Behavioural Brain Research},
  year = {2026},
  volume = {506},
  pages = {116149},
  doi = {10.1016/j.bbr.2026.116149}
}
Kostenlos starten →